MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Bruker Corporation Total Current Liabilities 2011-2026 | BRKR
Annual Total Current Liabilities Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.28 B | 1.2 B | 914 M | 938 M | 792 M | 646 M | 599 M | 524 M | 525 M | 555 M | 583 M | 649 M | 682 M | 756 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.28 B | 524 M | 760 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Insulet Corporation
PODD
|
680 M | $ 216.0 | -4.21 % | $ 15.2 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | USA |
 |
Quanterix Corporation
QTRX
|
74.8 M | $ 3.96 | 3.66 % | $ 169 M | USA |
 |
AVITA Medical
RCEL
|
62.7 M | $ 3.99 | 3.91 % | $ 111 M |  Australia |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
13 M | $ 1.33 | -1.85 % | $ 21.5 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
IRadimed Corporation
IRMD
|
10.2 M | $ 101.78 | 0.8 % | $ 1.29 B | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
3.73 M | $ 2.56 | -0.39 % | $ 7.1 M | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 37.08 | 1.42 % | $ 1.15 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Sensus Healthcare
SRTS
|
4.72 M | $ 4.22 | 6.57 % | $ 68.9 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
2.72 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
10.5 M | $ 24.66 | -0.16 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
Tactile Systems Technology
TCMD
|
41 M | $ 26.96 | 0.37 % | $ 617 M | USA |
 |
TELA Bio
TELA
|
17 M | $ 0.69 | -9.35 % | $ 15.8 M | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Tandem Diabetes Care
TNDM
|
243 M | $ 24.26 | -1.02 % | $ 1.65 B | USA |
 |
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.67 | -3.52 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
1.9 M | $ 2.32 | 7.41 % | $ 3.62 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
InspireMD
NSPR
|
10.7 M | $ 1.77 | -1.12 % | $ 114 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
712 M | $ 11.39 | -0.78 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
183 M | $ 336.27 | 0.63 % | $ 13.1 B | USA |
 |
Myomo
MYO
|
8.35 M | $ 0.7 | -0.1 % | $ 29.3 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
14 M | $ 2.29 | -4.58 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.71 | -5.12 % | $ 138 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 16.23 | 2.01 % | $ 381 M | USA |
 |
Outset Medical
OM
|
37.6 M | $ 3.53 | - | $ 53.7 K | USA |
 |
Inspire Medical Systems
INSP
|
96.1 M | $ 51.41 | -1.27 % | $ 1.51 B | USA |
 |
Varex Imaging Corporation
VREX
|
187 M | $ 10.69 | 0.66 % | $ 443 M | USA |